This was the stock's third consecutive day of losses.

AbbVie Inc (ABBV) stock saw a decline, ending the day at $179.53 which represents a decrease of $-0.57 or -0.32% from the prior close of $180.1. The stock opened at $179.63 and touched a low of ...

This was the stock's second consecutive day of losses.

AbbVie lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses ...

美国生物技术公司AbbVie(ABBV.US)下调2024财年调整後的每股盈利预测，由原先的10.9至10.94美元降至10.02至10.06美元，不及市场平均预期的10.94美元，因里程碑付款以及研究与开发成本相关的费用达到16亿美元。

In an SEC filing, AbbVie ABBV has disclosed that it is lowering its previously issued guidance for 2024 adjusted earnings per ...

BofA Securities has recently resumed AbbVie Inc (ABBV) stock to Neutral rating, as announced on December 10, 2024, according to Finviz. Earlier, on December 5, 2024, Daiwa Securities had reduced the ...

Boltwood Capital Management decreased its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.4% in the 4th quarter, ...

We recently compiled a list of the Top 20 Dividend Stocks of 2024. In this article, we are going to take a look at where ...

DCF analysis, a reliable and data-driven approach to estimating its intrinsic value. Instead of using future free cash flow as in the traditional DCF model, the GuruFocus DCF calculator uses EPS ...

据报告统计，全球与中国炎症性肠病（IBD）市场在2023年的市场规模分别为 亿元（人民币）与 亿元。通过深入分析市场增长规律，报告对未来炎症性肠病（IBD）市场的变化趋势进行客观的预测，炎症性肠病（IBD）市场规模预计将在2029年达 亿元。

We recently compiled a list of the 13 Best Pharma Dividend Stocks To Buy In 2024. In this article, we are going to take a ...